Publications by authors named "Heather H Cheng"

58Publications

Two Steps Forward and One Step Back for Precision in Prostate Cancer Treatment.

J Clin Oncol 2020 Nov 8;38(32):3740-3742. Epub 2020 Sep 8.

Division of Oncology, Department of Medicine, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.01755DOI Listing
November 2020

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.

J Clin Oncol 2020 Aug 9;38(24):2798-2811. Epub 2020 Jun 9.

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.20.00046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430215PMC
August 2020

Honing in on PARPi Response in Prostate Cancer: from HR Pathway to Gene-by-Gene Granularity.

Clin Cancer Res 2020 Jun 31;26(11):2439-2440. Epub 2020 Mar 31.

Department of Medicine, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-20-0707DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269828PMC
June 2020

Genetic Testing in Prostate Cancer.

Curr Oncol Rep 2020 01 23;22(1). Epub 2020 Jan 23.

Department of Medicine, University of Washington, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-020-0863-6DOI Listing
January 2020

Ethnic disparities among men with prostate cancer undergoing germline testing.

Urol Oncol 2020 03 17;38(3):80.e1-80.e7. Epub 2019 Oct 17.

Department of Medicine, Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2019.09.010DOI Listing
March 2020

Current recommendations for prostate cancer genetic testing: NCCN prostate guideline.

Can J Urol 2019 Oct;26(5 Suppl 2):34-37

Departments of Urology and Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.

View Article

Download full-text PDF

Source
October 2019

Germline contributions to metastatic prostate cancer.

Authors:
Heather H Cheng

Can J Urol 2019 Oct;26(5 Suppl 2):19-21

Department of Medicine, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
October 2019

Germline and Somatic Mutations in Prostate Cancer for the Clinician.

J Natl Compr Canc Netw 2019 05;17(5):515-521

Division of Medical Oncology, University of Washington, and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2019.7307DOI Listing
May 2019

Time from definitive therapy to onset of metastatic disease predicts outcomes in men with metastatic hormone sensitive prostate cancer.

Urol Oncol 2019 06 13;37(6):352.e19-352.e24. Epub 2019 Feb 13.

Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2019.01.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6857455PMC
June 2019

The resounding effect of DNA repair deficiency in prostate cancer.

Authors:
Heather H Cheng

Urol Oncol 2018 08 17;36(8):385-388. Epub 2018 Mar 17.

Division of Medical Oncology, University of Washington, Seattle, WA; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439183007
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2018.02.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746340PMC
August 2018

Polyclonal Reversion Mutations Detected in Circulating Tumor DNA After Platinum Chemotherapy in a Patient With Metastatic Prostate Cancer.

JCO Precis Oncol 2018 14;2. Epub 2018 Feb 14.

All authors, University of Washington; and , Fred Hutchinson Cancer Research Center; and , Veterans Affairs Puget Sound Health Care System, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/PO.17.00169DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446371PMC
February 2018

Hepatitis C infection and chemotherapy toxicity.

J Oncol Pharm Pract 2019 Mar 11;25(2):474-480. Epub 2017 Oct 11.

1 Department of Pharmacy, University of Washington Medicine/Seattle Cancer Care Alliance, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155217734626DOI Listing
March 2019

Prostate Cancer Screening in a New Era of Genetics.

Clin Genitourin Cancer 2017 12 31;15(6):625-628. Epub 2017 May 31.

Department of Medicine, University of Washington, Seattle, WA; Fred Hutchinson Cancer Research Center, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.05.024DOI Listing
December 2017

Screening Men at Increased Risk for Prostate Cancer Diagnosis: Model Estimates of Benefits and Harms.

Cancer Epidemiol Biomarkers Prev 2017 02 14;26(2):222-227. Epub 2016 Oct 14.

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-16-0434DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5296376PMC
February 2017

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.

N Engl J Med 2016 Aug 6;375(5):443-53. Epub 2016 Jul 6.

From the University of Washington (C.C.P., M. Beightol, C.M., B.N., H.H.C., B.M., T.W., S. Casadei, P.S.N.) and Fred Hutchinson Cancer Research Center (N.D.S., R.G., P.S.N.) - both in Seattle; the Institute of Cancer Research and Royal Marsden Hospital, London (J.M., S. Carreira, R.E., J.B.); Memorial Sloan Kettering Cancer Center (M.F.W., W.A., M. Berger, L.Z., A.Z., J. Vijai, H.I.S., C.S., N.S., P.W.K., D.S., M.R., K.O.), Weill Cornell Medical College (H.B., O.E., M.A.R.), and the Prostate Cancer Clinical Trials Consortium (J. Vinson, J.F.) - all in New York; the University of Michigan, Ann Arbor (D.R., R.L., M.H., A.C.); Howard Hughes Medical Institute, Chevy Chase, MD (A.C., C.S.); and Dana-Farber Cancer Institute, Boston (A.G., L.G., M.-E.T., S.A., G.C.H., E.M.V.A.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1603144DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986616PMC
August 2016

Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancer.

Med Oncol 2016 Jul 14;33(7):77. Epub 2016 Jun 14.

Division of Oncology, Department of Medicine, University of Washington, Seattle, WA, 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-016-0793-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298886PMC
July 2016

Biallelic Inactivation of BRCA2 in Platinum-sensitive Metastatic Castration-resistant Prostate Cancer.

Eur Urol 2016 06 24;69(6):992-5. Epub 2015 Dec 24.

Department of Medicine, Division of Oncology, University of Washington, Seattle, WA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.11.022DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909531PMC
June 2016

Integrative clinical genomics of advanced prostate cancer.

Cell 2015 May;161(5):1215-1228

Michigan Center for Translational Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Department of Urology, University of Michigan Medical School, Ann Arbor, MI 48109, USA; Howard Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2015.05.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484602PMC
May 2015

SWOG S0925: A Randomized Phase II Study of Androgen Deprivation Combined With Cixutumumab Versus Androgen Deprivation Alone in Patients With New Metastatic Hormone-Sensitive Prostate Cancer.

J Clin Oncol 2015 May 6;33(14):1601-8. Epub 2015 Apr 6.

Evan Y. Yu, Hongli Li, Celestia S. Higano, Heather H. Cheng, and Catherine M. Tangen, Fred Hutchinson Cancer Research Center, University of Washington; Stephen R. Plymate, Harborview Medical Center, University of Washington, Seattle; Yoshio Inoue, Multicare Regional Cancer Center, Tacoma, WA; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Sumanta K. Pal, City of Hope, Duarte; David I. Quinn, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA; Ajjai Alva, University of Michigan, Ann Arbor; Elisabeth I. Heath, Karmanos Cancer Center, Wayne State University, Detroit, MI; Elaine T. Lam, University of Colorado, Denver, CO; Shilpa Gupta, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida Morisani College of Medicine, Tampa, FL; Michael B. Lilly, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC; Kim N. Chi, British Columbia Cancer Agency, University of British Columbia, Vancouver, British Columbia, Canada; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; and Ian M. Thompson Jr, University of Texas Health Science Center at San Antonio, San Antonio, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.59.4127DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417730PMC
May 2015

Quantitative and stoichiometric analysis of the microRNA content of exosomes.

Proc Natl Acad Sci U S A 2014 Oct 29;111(41):14888-93. Epub 2014 Sep 29.

Divisions of Human Biology, Departments of Internal Medicine and Clinical Research, Biomedical Engineering, Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; Biointerfaces Institute, and Center for Computational Medicine, University of Michigan, Ann Arbor, MI 48109; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1408301111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205618PMC
October 2014

Long-term survival in bone-predominant metastatic urothelial carcinoma.

Clin Genitourin Cancer 2014 Dec 23;12(6):e241-4. Epub 2014 Jul 23.

Department of Medicine, Division of Oncology, University of Washington School of Medicine, Seattle, WA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.07.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4252264PMC
December 2014

Glucocorticoids and prostate cancer treatment: friend or foe?

Asian J Androl 2014 May-Jun;16(3):354-8

Department of Medicine, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/1008-682X.125392DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023359PMC
December 2014

Role of maximal endoscopic resection before cystectomy for invasive urothelial bladder cancer.

Clin Genitourin Cancer 2014 Aug 23;12(4):287-91. Epub 2014 Jan 23.

Department of Urology, University of Washington School of Medicine, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2014.01.005DOI Listing
August 2014

Pathologic Response Rates of Gemcitabine/Cisplatin versus Methotrexate/Vinblastine/Adriamycin/Cisplatin Neoadjuvant Chemotherapy for Muscle Invasive Urothelial Bladder Cancer.

Adv Urol 2013 8;2013:317190. Epub 2013 Dec 8.

Department of Urology, University of Washington School of Medicine, Seattle, WA 98195, USA ; Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/au/2013/317190/
Publisher Site
http://dx.doi.org/10.1155/2013/317190DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3871504PMC
January 2014

Advanced clinical states in prostate cancer.

Urol Clin North Am 2012 Nov 12;39(4):561-71. Epub 2012 Sep 12.

Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00940143120005
Publisher Site
http://dx.doi.org/10.1016/j.ucl.2012.07.011DOI Listing
November 2012

MicroRNA profiling: approaches and considerations.

Nat Rev Genet 2012 Apr 18;13(5):358-69. Epub 2012 Apr 18.

Department of Laboratory Medicine, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrg3198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4517822PMC
April 2012

Feline leukemia virus T entry is dependent on both expression levels and specific interactions between cofactor and receptor.

Virology 2007 Mar 13;359(1):170-8. Epub 2006 Oct 13.

Program in Molecular and Cellular Biology, University of Washington, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S004268220600647
Publisher Site
http://dx.doi.org/10.1016/j.virol.2006.09.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1820874PMC
March 2007

Envelope determinants for dual-receptor specificity in feline leukemia virus subgroup A and T variants.

J Virol 2006 Feb;80(4):1619-28

Division of Human Biology, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Mail Stop C3-168, Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JVI.80.4.1619-1628.2006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1367127PMC
February 2006